Evercore ISI Cuts AbbVie Inc. (ABBV) PT, Says Consensus for 2026 and 2027 Still Looks Beatable
AbbVie Inc. (NYSE:ABBV) is included among the 13 Best Roth IRA Stocks to Buy Now. Evercore ISI Cuts AbbVie Inc.…
Tag: AbbVie
AbbVie Raises 2026 Earnings Forecast as Botox Sales Rebound
AbbVie Inc. forecast 2026 profits above Wall Street’s expectations, as efforts to revive its sagging aesthetics business start to pay…
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research
AbbVie Inc. (NYSE:ABBV) is one of the best performing pharma stocks in 2025. AbbVie Inc. (NYSE:ABBV) was downgraded to Peer…
AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share
AbbVie Inc. (NYSE:ABBV) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the…
AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More
Thinkstock It’s likely that the Federal Reserve Chairman Jay Powell will announce a 25-basis-point rate cut this afternoon. Traders are…
AbbVie (ABBV) Surged Following Strong Results and Increased Guidance
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter 2025 investor letter. A copy…
Analyst Report: AbbVie Inc
Analyst Report: AbbVie Inc finance.yahoo.com #Analyst #Report #AbbVie
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan…
AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial
AbbVie Inc. (NYSE:ABBV) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18,…